全球,肝细胞癌（HCC）是癌症相关死亡的第三大常见原因。近年来在治疗HCC方面取得的显着进步增加了HCC管理的复杂性。根据需要更新HCC多学科治疗管理指南，参与这种癌症管理的意大利科学协会推动起草了一份新的专门文件。本文件是根据根据证据制定指南所需的GRADE方法起草的。以下是指南的第一部分，专注于多学科肿瘤专家委员会和肝癌的外科治疗。
Worldwide, hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death. The remarkable improvements in treating HCC achieved in the last years have increased the complexity of HCC management. Following the need to have updated guidelines on the multidisciplinary treatment management of HCC, the Italian Scientific Societies involved in the management of this cancer have promoted the drafting of a new dedicated document. This document was drawn up according to the GRADE methodology needed to produce guidelines based on evidence. Here is presented the first part of guidelines, focused on the multidisciplinary tumor board of experts and surgical treatments of HCC.
